Dow Jones

39,954.31

0.21%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Auris Medical Holding AG (EARS)
Auris Medical Holding AG (EARS) Noticias

EARS

Auris Medical (EARS)

Auris Medical Holding AG

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:EARS

1 2 3 4 5 6 7 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
27/06/2023	15:46	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:EARS	Auris Medical Holding AG
16/06/2023	16:02	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1)	NASDAQ:EARS	Auris Medical Holding AG
12/06/2023	05:44	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:EARS	Auris Medical Holding AG
09/06/2023	15:37	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:EARS	Auris Medical Holding AG
27/04/2023	15:34	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:EARS	Auris Medical Holding AG
17/04/2023	11:22	Edgar (US Regulatory)	Certification by the Exchange Approving Securities for Listing (cert)	NASDAQ:EARS	Auris Medical Holding AG
13/04/2023	07:20	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	NASDAQ:EARS	Auris Medical Holding AG
11/04/2023	15:02	Edgar (US Regulatory)	Securities Registration (section 12(b)) (8-a12b)	NASDAQ:EARS	Auris Medical Holding AG
11/04/2023	15:02	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	NASDAQ:EARS	Auris Medical Holding AG
27/03/2023	09:34	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1/a)	NASDAQ:EARS	Auris Medical Holding AG
23/09/2022	15:32	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3)	NASDAQ:EARS	Auris Medical Holding AG
14/04/2022	15:53	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:EARS	Auris Medical Holding AG
12/04/2022	07:02	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:EARS	Auris Medical Holding AG
08/12/2021	15:38	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:EARS	Auris Medical Holding AG
16/07/2021	08:00	GlobeNewswire Inc.	Auris Medical Announces Launch of New Corporate Website	NASDAQ:EARS	Auris Medical Holding AG
14/07/2021	08:00	GlobeNewswire Inc.	Auris Medical Announces Publication of Data from Preclinical Studies with Bentrio™ Nasal Spray in Prevention and Mitigation...	NASDAQ:EARS	Auris Medical Holding AG
06/07/2021	08:00	GlobeNewswire Inc.	Auris Medical to Develop KRAS-Targeting RNA Treatment for Colorectal Cancer as First Therapeutic Indication for OligoPhore™...	NASDAQ:EARS	Auris Medical Holding AG
28/06/2021	07:30	GlobeNewswire Inc.	Auris Medical to Initiate Market Launch of Bentrio™ Nasal Spray in Germany	NASDAQ:EARS	Auris Medical Holding AG
21/06/2021	07:30	GlobeNewswire Inc.	Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adul...	NASDAQ:EARS	Auris Medical Holding AG
03/06/2021	06:30	GlobeNewswire Inc.	Auris Medical Announces Acquisition of RNA Therapeutics Company and Plans for Strategic Repositioning	NASDAQ:EARS	Auris Medical Holding AG
01/06/2021	07:30	GlobeNewswire Inc.	Auris Medical Starts Preparations for Covid-19 Trial with Bentrio in India	NASDAQ:EARS	Auris Medical Holding AG
28/05/2021	07:30	GlobeNewswire Inc.	Auris Medical Holding to Present at LD Micro Invitational XI Conference	NASDAQ:EARS	Auris Medical Holding AG
25/05/2021	08:00	GlobeNewswire Inc.	Auris Medical Announces Completion of Bentrio Conformity Assessment Procedure for Marketing in EU	NASDAQ:EARS	Auris Medical Holding AG
14/05/2021	07:30	GlobeNewswire Inc.	Auris Medical Reaches Midpoint for Enrollment in Part B of AM-125 Phase 2 TRAVERS Trial in Acute Peripheral Vertigo	NASDAQ:EARS	Auris Medical Holding AG
07/05/2021	08:05	GlobeNewswire Inc.	Auris Medical Provides Update on Bentrio Program in Allergy	NASDAQ:EARS	Auris Medical Holding AG
13/04/2021	06:45	GlobeNewswire Inc.	Auris Medical Announces Positive Preclinical and Clinical Outcomes with AM-301 and Details Plans for Market Launch	NASDAQ:EARS	Auris Medical Holding AG
08/04/2021	07:00	GlobeNewswire Inc.	Auris Medical to Provide Business Update on AM-301 Program on Tuesday, April 13, 2021	NASDAQ:EARS	Auris Medical Holding AG
31/03/2021	07:30	GlobeNewswire Inc.	Auris Medical Provides Business Update and Reports Second Half and Full Year 2020 Financial Results	NASDAQ:EARS	Auris Medical Holding AG
24/03/2021	07:00	GlobeNewswire Inc.	Auris Medical to Report Second Half and Full Year 2020 Financial Results and Provide Business Update on Wednesday, March 31, ...	NASDAQ:EARS	Auris Medical Holding AG
29/01/2021	07:30	GlobeNewswire Inc.	Auris Medical Announces Initiation of Clinical Investigation of AM-301 in Allergic Rhinitis	NASDAQ:EARS	Auris Medical Holding AG